share_log

Is STAAR Surgical Company (NASDAQ:STAA) Potentially Undervalued?

Simply Wall St ·  Aug 28, 2022 09:50

STAAR Surgical Company (NASDAQ:STAA), might not be a large cap stock, but it saw a significant share price rise of over 20% in the past couple of months on the NASDAQGM. With many analysts covering the mid-cap stock, we may expect any price-sensitive announcements have already been factored into the stock's share price. However, could the stock still be trading at a relatively cheap price? Let's examine STAAR Surgical's valuation and outlook in more detail to determine if there's still a bargain opportunity.

Check out our latest analysis for STAAR Surgical

What's The Opportunity In STAAR Surgical?

The stock is currently trading at US$98.49 on the share market, which means it is overvalued by 27% compared to my intrinsic value of $77.30. This means that the opportunity to buy STAAR Surgical at a good price has disappeared! If you like the stock, you may want to keep an eye out for a potential price decline in the future. Since STAAR Surgical's share price is quite volatile, this could mean it can sink lower (or rise even further) in the future, giving us another chance to invest. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

What kind of growth will STAAR Surgical generate?

earnings-and-revenue-growthNasdaqGM:STAA Earnings and Revenue Growth August 28th 2022

Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. STAAR Surgical's earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value.

What This Means For You

Are you a shareholder? STAA's optimistic future growth appears to have been factored into the current share price, with shares trading above its fair value. At this current price, shareholders may be asking a different question – should I sell? If you believe STAA should trade below its current price, selling high and buying it back up again when its price falls towards its real value can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.

Are you a potential investor? If you've been keeping tabs on STAA for some time, now may not be the best time to enter into the stock. The price has surpassed its true value, which means there's no upside from mispricing. However, the positive outlook is encouraging for STAA, which means it's worth diving deeper into other factors in order to take advantage of the next price drop.

So while earnings quality is important, it's equally important to consider the risks facing STAAR Surgical at this point in time. You'd be interested to know, that we found 1 warning sign for STAAR Surgical and you'll want to know about this.

If you are no longer interested in STAAR Surgical, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment